Sandy Spring Bank lowered its stake in shares of Laboratory Co. of America Holdings (NYSE:LH – Get Rating) by 2.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,785 shares of the medical research company’s stock after selling 778 shares during […]
M. Kulyk & Associates LLC raised its stake in Laboratory Co. of America Holdings (NYSE:LH – Get Rating) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,101 shares of the medical research company’s stock after acquiring an additional 508 […]
Laboratory Co. of America (NYSE:LH – Get Rating) had its target price reduced by Citigroup from $260.00 to $235.00 in a research note issued to investors on Wednesday morning, The Fly reports. A number of other equities analysts have also commented on the stock. Truist Financial raised their price objective on shares of Laboratory Co. […]
Cambiar Investors LLC bought a new position in shares of Laboratory Co. of America Holdings (NYSE:LH – Get Rating) during the 4th quarter, Holdings Channel reports. The firm bought 208,800 shares of the medical research company’s stock, valued at approximately $49,168,000. Laboratory Co. of America accounts for about 2.2% of Cambiar Investors LLC’s investment portfolio, […]
WealthBridge Investment Counsel Inc. trimmed its position in shares of Laboratory Co. of America Holdings (NYSE:LH – Get Rating) by 0.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,976 shares of the medical research company’s stock after selling 150 […]